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Abstract
Nephrogenic adenoma, also referred to nephrogenic metaplasia, is a benign proliferative lesion of urothelium,
usually associated with chronic physical stimuli or inflammation. Familial Mediterranean fever is an inherited
autosomal recessive disease characterized by recurrent short episodes of fever. The site of mutation is found in
MEFV gene which controls inflammatory responses. We have experienced a case of nephrogenic adenoma in a
16-year-old girl with Familial Mediterranean Fever, showing proliferative lesions diffusely in the urinary bladder and
multifocally in the other parts of urinary tract. These lesions disappeared after colchicine treatment. We searched for
MEFV gene mutation using the specimen from the resected urinary bladder and detected heterozygous mutation
of E148Q. There is a possibility that control of inflammation caused by the surgery for vesicoureteral reflux in the
local site didn’t work well on the background of heterozygous mutation of MEFV gene, and as a result, nephrogenic
adenoma appeared. This is the first report of a combination of two rare diseases. We have to be aware that
nephrogenic adenoma can occur in association with Familial Mediterranean Fever, and the former condition should
be taken into consideration when rendering a correct pathological diagnosis.
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Background
Nephrogenic adenoma is a benign tumor-like lesion of
the urinary tract, characterized by a papillary and tubu-
lar proliferation of cuboidal cells similar to the epithelial
cells of distal renal tubules. It occurs anywhere in the
urinary tract, but it is most frequently found in the blad-
der [1]. It was first described in 1949 by Davis [2], and
originally thought to arise from a remnant of mesoneph-
ric tissue or metaplasia of the urothelium in response to
chronic irritation and mucosal damage. Currently, it is
known that exfoliated and implanted renal tubular cells
into the urinary tract mucosa form the disease [3]. The
most common histological pattern is a proliferation of
small tubules composed of a single layer of cuboidal epi-
thelium. These tubules are often surrounded by a hyali-
nized basement membrane and contain blue mucin in
the lumens. It may also grow in papillary, cystic or solid
pattern. Hobnail cells may be seen in papillary growth
areas. In cystic pattern, colloid-like eosinophilic secre-
tion or blue-tinged mucin is frequently observed [1]. Oc-
casionally, clear cells or signet-ring cells can be seen in
solid area, which could be confused with poorly differen-
tiated adenocarcinoma. Although it arises commonly in
adults, approximately 10 % of the patients are children,
and several cases of even younger patients have been re-
ported in the literature [4–7].
Familial Mediterranean fever (FMF) was first reported
as ‘benign paroxysmal peritonitis’ in 1945 [8] and the
current name of the disease was proposed in 1958 [9].
Most of the reported cases are autosomal recessive dis-
ease characterized by recurrent short episodes of fever
and pain due to serosal inflammation [10]. In 1997, a re-
sponsible gene was cloned and named MEFV. It encodes
a protein pyrin that controls inflammation [11, 12]. Fre-
quent mutations have been found in M694V, M694I,
V726A, M680I of exon10 and, E148Q of exon 2 [13].
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This disease is most common in the periodic fever syn-
drome and characterized by high effectiveness of colchi-
cine administration [14]. We present the first rare case
of nephrogenic adenoma secondary to FMF, occurring
throughout the urinary tract. There has been no such a
report in the literature and also, it is very rare that
nephrogenic adenoma involves almost the whole mucosa
of urinary tract.
Case presentation
A 16-year-old girl presented with disturbed conscious-
ness and was admitted to our hospital under the diagno-
sis of hypertonic dehydration. During the pregnancy
(32 weeks of gestational age) of her mother (29-year-old
at that time), she was born by an urgent cesarean section
for a shock state due to rupture of the right ovary me-
tastasized by gastric cancer. The mother died of gastric
cancer at the age of 33. The patient presented with fetal
distress syndrome at birth, and thereby had sequelae
such as developmental and mental retardation and epi-
lepsy. Thereafter, she repeated urinary tract infection
(UTI) caused by vesicoureteral reflux. However, even
after the surgery, remittent fever came to arise twice or
three times a month, but causative bacteria could not be
identified by either urinalysis or urine culture. Leukocytosis
and slightly high level of CRP (C-reactive protein) contin-
ued to be observed. Immunological test revealed slightly
low value of CH50. On admission, swelling of left kidney
was pointed out with the abdominal computed tomog-
raphy. Abdominal ultrasonography revealed the left hydro-
ureteronephrosis associated with a bladder mass. In the
meantime, the tumor gradually enlarged to fill the whole
lumen of the bladder, and she finally developed bilateral
hydroureteronephrosis. As a result, the patient underwent
total cystectomy followed by cutaneous ureterostomy.
Grossly, papillary or villous mass totally occupied the
bladder lumen measured 7 cm in the maximum diameter
(Fig. 1). Histologically, various patterns of structure were
observed. The most predominant pattern was villous
architecture with delicate core vessels, composed of hob-
nail tumor cells with high N/C ratio (Fig. 2a and b). Areas
of small gland proliferation and cystic change were also
seen, both of which had colloid-like eosinophilic secretion
in the lumens (Fig. 2c and d). In addition, proliferation of
microtubules was also observed, simulating poorly dif-
ferentiated adenocarcinoma or signet-ring cell carcinoma
(Fig. 2e and f). Mucin was identified in PAS/Alcian-blue
double staining (Fig. 2g).
Formaline-fixed, paraffin-embedded (FFPE) tissue was
cut into sections of 3 μm thickness and immunostain
was performed with the primary antibodies (Table 1) ac-
cording to the manufacturers’ instructions and visualized
employing Ventana BenchMark ULTRA immunostainer
(Ventana Medical Systems, USA). Immunohistochemi-
cally, the tumor cells were positive for CK7, α-methyl-
acyl-CoA racemase (AMACR), CA19-9, vimentin (Fig. 2h),
PAX8 (Fig. 2i and j), PAX2 (Fig. 2k), CD138 and CD10,
and negative for p63 and prostate specific protein (PSA).
The Ki-67-positive cells were very few (Fig. 2l). In the
background, cystitis glandularis with hypeplastic urothe-
lium was observed with variety of inflammatory cell infil-
tration, including neutrophils, mast cells and plasma cells.
These histological findings were consistent with nephro-
genic adenoma. After surgery, papillary lesion recurred in
Fig. 1 Gross appearance of resected bladder; Papillary or villous projections are observed in the lumen of the bladder (a: whole image,
b: cut surface)
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Fig. 2 (See legend on next page.)
Ishikawa et al. Diagnostic Pathology  (2015) 10:104 Page 3 of 7
the bilateral renal pelvises and nearby ureters, but most of
the recurrent lesions disappeared by colchicine treatment.
Considering the effectiveness of colchicine treatment,
we searched for MEFV gene mutations. In Japan, about
100 cases of FMF have been reported with frequent mu-
tations found in E148Q (exon2) and M694I (exon10), so
we searched for these mutations using formalin fixed
samples of this case. Genomic DNA was extracted from
10 FFPE sections of 10 μm thickness using QIAamp
DNA FFPE tissue kit (QIAGEN, Venio, Netherland) ac-
cording to the manufacturer’s recommendations. The
following PCR primers were used for amplification of





Thermal cycling conditions were 5 min at 94 °C,
followed by 35 cycles of 94 °C for 30 s, 62 °C(exon 2) or
56 °C (exon 10) for 30 s and 72 °C for 1 min followed by
a final incubation at 72 °C for 7 min. The PCR products
were purified using QIAquick PCR purification kit
(QIAGEN, Venio, Netherland). After purification of PCR
products, analyses by capillary electrophoresis on a 3130
Genetic Analyzer (Applied Biosystems, Foster City, CA)
were performed. Sequence electropherograms were an-
alyzed by Sequence Analysis 5.2 software (Applied
Biosystems). As a result, we could not find any
mutations in exon 10 but a heterozygous mutation of
E148Q was detected in exon2 (Fig. 3).
Discussion
In the past, nephrogenic adenoma was thought to arise
from the remnant of embryogenic mesonephric tissue in
the urinary tract, or from metaplastic change of urothe-
lium due to inflammation or injury. In 1981, Bhagavan
et al. examined nephrogenic adenoma morphologically
with electron microscopy and found the presence of
Tamm-Horsfall protein [15]. They revealed that this lesion
was of mesonephric origin rather than of metanephric.
Based on the fact that the nephrogenic adenoma often oc-
curs in patients who received kidney transplantation,
Mazal et al. in 2002 [3] made a research into the origin of
nephrogenic adenoma. They analyzed X and Y chromo-
somes employing fluorescence in situ hybridization. In the
cases of male recipients from female donors, the cells of
nephrogenic adenoma had XX chromosome pattern, On
the contrary, in the cases of female recipients from male
donors, the cells had XY chromosome pattern. These re-
sults indicated that origin of nephrogenic adenoma was
donor-derived renal cells [3]. Moreover they thought
nephrogenic adenoma in extrarenal organs like urinary
bladder was caused by proliferation of cells of renal origin,
and showed positive immunostaining of PAX2 [16]. PAX2
is a transcriptional factor in development and expressed in
renal tubular cells and parietal cells of the Bowman’s
(See figure on previous page.)
Fig. 2 Histologic appearances of nephrogenic adenoma. a The tumor proliferated in very thin villous pattern with delicate core vessels. b Hobnail
structure of the tumor cells with high N/C ratio was identified. Various size of glands were seen. c Comparatively small glands and (d) large
glands with cystic change. Both of them had colloid-like eosinophilic secretion in the lumens. e, f Microtubular structures were also observed.
They were quite similar to poorly differentiated adenocarcinoma or signet-ring cell carcinoma in part. g Mucin could be identified with PAS/
Alcian-blue double stain. h Vimentin was diffusely positive with immunohistochemical analysis. i, j PAX8 was diffusely positive in all histological
structures of nephrogenic adenoma. k PAX2 was also positive. l Ki-67 postive cells were very few
Table 1 Summary of antibodies employed in this case
Marker Antibody Source Dilution
CK7 Anti-Human Cytokeratin 7, monoclonal, Clone OV-TL 12/30 Dako, Glostrup, Denmark 1:100
AMACR Anti-Human P504S, rabbit monoclonal, Clone 13H4 Dako, Glostrup, Denmark 1:100
CA19-9 Anti-CA19-9, mouse monoclonal, Clone BC/121SLE Biocare, Concord, USA 1:100
Vimentin Anti-Vimentin, mouse monoclonal, Clone V9 Dako, Glostrup, Denmark 1:100
CD138 Anti-Human CD138, monoclonal, Clone MI15 Dako, Glostrup, Denmark 1:50
CD10 Anti-CD10, rabbit monoclonal, Clone SP67 Roche, Basel, Switzerland 1:1 (prediluted)
p63 Anti-p63, mouse monoclonal, Clone BC4A4 Biocare, Concord, USA 1:200
PSA Anti-Human Prostate-Specfic Antigen, Clone ER-PR8 Dako, Glostrup, Denmark 1:50
PAX8 Anti-Pax8, mouse monoclonal, Clone BCl2 Biocare, Concord, USA 1:1 (prediluted)
PAX2 Anti-Pax2, rabbit monoclonal, Clone EP3251 Abcam, Cambridge, UK 1:1000
Ki-67 Anti-Ki67, rabbit monoclonal, Clone 30-9 Roche, Basel, Switzerland 1:1 (prediluted)
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capsule of gromerulus [16]. PAX2 has recently been con-
sidered to be one of the useful markers for nephrogenic
adenoma [16]. “ PAX8, another transcriptional factor,
expressed in renal cells is also positive in nephrogenic ad-
enoma [17]. It is currently thought that dislodged renal
tubular epithelial cells are transplanted into the urinary
tract mucosa and engraftment occurs, resulting in the dis-
ease [3]. In the present case, repeated urinary tract infec-
tion might have contributed to the development of
nephrogenic adenoma. We consider that occurrence of
the tumor in renal pelvis of both sides after bladder ex-
traction supported this hypothesis.
About 10 % of the cases with nephrogenic adenoma
occur in pediatric age [1], and show the same morpho-
logical and immunohistochemical features as adult cases
[18]. They occur under the specific pathological conditions
such as Turner's syndrome [4] or prune belly syndrome
[5]. Multifocal [6] and/or diffuse [7] lesions have also been
reported. FMF is known to cause inflammatory conditions
such as peritonitis, pleurisy, arthritis, erysipelas-like
erythema and pericarditis. Responsible gene of FMF lo-
cated at chromosome 16p13.3 encodes a pyrin/marenos-
trin protein composed of 781 amino acids and consists of
10 exons [11, 12]. Usually, pyrin has N-terminal PYRIN
domain and C-terminal B30.2 domain. Activity of caspase-
1 is regulated by ASC (apotosis-associated speck-like pro-
tein which contains a caspase recruitment domain) which
bound to PYRIN domain and, B30.2 domain also regulates
activity of IL-1β by directely inhibition of caspase-1 activa-
tion [19, 20]. Major mutations of FMF are found in E148Q
in exon 2, and M894V, M694I, V726A, and M680I in exon
10 of PYD [21, 22]. If there is a mutation in exon 10, the
diagnosis of FMF can be confirmed. Additionally, if muta-
tions in the other exons, including heterozygous mutation
are detected, colchicine can be utilized not only for a treat-
ment, but also for a diagnosis of FMF variant [23]. In FMF
variants, mutations in exon 1 (E84K), exon 2 (L110P,
E148Q, R202Q, G304R), exon 3 (P369S, R408Q) and
exon5 (S503C) are known. It is believed that inflammation
is provoked by missense mutations of PYRIN gene which
A
B
Fig. 3 Sequence analysis of exon 2. a Heterozygous point mutation of E148Q was detected. b Enlarged view of mutation area. Spine of blue line
is C: cytosine and those of black line are G: guanine of base DNA
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result in loss of suppressive function of inflammasome
and increase of IL-1β production [19, 20]. In our case,
only one heterozygous mutation of E148Q (exon2) was
observed. There is a report that this mutation was seen in
20 % of Japanese patients [24], but the present case was
diagnosable as FMF variant, because treatment with col-
chicine was very effective. We did not search for other
mutations on the chromosome, because most of them are
limited at E148Q (exon2) and, M694I (exon 10) in the
Japanese patients. Pyrin, located in microtubules and actin
[25], is a protein highly expressed in white blood cells.
They are coded by MEFV gene which regulates inflamma-
tory response by interacting with the cytoskeletons and
mutation of this gene probably decreased or deleted its
function [25]. Colchicine also has a function to inhibit the
polymerization of microtubules (tubulin). In the present
case, not only white blood cells but also the tumor cells of
nephrogenic adenoma were positive for vimentin. This
suggests the possibility of expression of tubulin (compo-
nent of cytokelaton). Many of the FMF cases are auto-
somal recessive, and the symptoms are less likely to occur
in heterozygous mutation of E148Q (exon 2), so that the
patient might have different mutations to cause the
symptoms.
Conclusion
To our knowledge, this is the first report of nephrogenic
adenoma in a FMF patient. We speculate that control of in-
flammation in the local site didn’t work well on the back-
ground of heterozygous mutation of MEFV gene, thus,
being triggered by mechanical operation of urinary tract,
proliferation of nephrogenic adenoma was induced. How-
ever, an accumulation of the similar cases is mandatory to
clearly elucidate the mechanisms of the disease. Further-
more, we should be aware that nephrogenic adenoma can
occur in FMF patients to render a correct diagnosis.
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